260 related articles for article (PubMed ID: 31215667)
1. The pan-cancer mutational landscape of the PPAR pathway reveals universal patterns of dysregulated metabolism and interactions with tumor immunity and hypoxia.
Chang WH; Lai AG
Ann N Y Acad Sci; 2019 Jul; 1448(1):65-82. PubMed ID: 31215667
[TBL] [Abstract][Full Text] [Related]
2. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types.
Chang WH; Lai AG
BMC Cancer; 2020 Aug; 20(1):773. PubMed ID: 32807122
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
Latruffe N; Vamecq J
Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator-activated receptors under epigenetic control in placental metabolism and fetal development.
Lendvai Á; Deutsch MJ; Plösch T; Ensenauer R
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E797-810. PubMed ID: 26860983
[TBL] [Abstract][Full Text] [Related]
5. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
[TBL] [Abstract][Full Text] [Related]
6. [The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis].
Knapp P; Jarzabek K; Błachnio A; Zbroch T
Ginekol Pol; 2006 Aug; 77(8):643-51. PubMed ID: 17076197
[TBL] [Abstract][Full Text] [Related]
7. Effects of Diisodecyl Phthalate on PPAR:RXR-Dependent Gene Expression Pathways in Sea Bream Hepatocytes.
Cocci P; Mosconi G; Arukwe A; Mozzicafreddo M; Angeletti M; Aretusi G; Palermo FA
Chem Res Toxicol; 2015 May; 28(5):935-47. PubMed ID: 25825955
[TBL] [Abstract][Full Text] [Related]
8. PPARs at the crossroads of lipid signaling and inflammation.
Wahli W; Michalik L
Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720
[TBL] [Abstract][Full Text] [Related]
9. PPAR trilogy from metabolism to cancer.
Nahlé Z
Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):397-402. PubMed ID: 15192441
[TBL] [Abstract][Full Text] [Related]
10. Aberrations in Notch-Hedgehog signalling reveal cancer stem cells harbouring conserved oncogenic properties associated with hypoxia and immunoevasion.
Chang WH; Lai AG
Br J Cancer; 2019 Oct; 121(8):666-678. PubMed ID: 31523055
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases.
Khuchua Z; Glukhov AI; Strauss AW; Javadov S
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400386
[TBL] [Abstract][Full Text] [Related]
12. Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.
Haider S; McIntyre A; van Stiphout RG; Winchester LM; Wigfield S; Harris AL; Buffa FM
Genome Biol; 2016 Jun; 17(1):140. PubMed ID: 27358048
[TBL] [Abstract][Full Text] [Related]
13. Metabolic control of PPAR activity by aldehyde dehydrogenase regulates invasive cell behavior and predicts survival in hepatocellular and renal clear cell carcinoma.
Andrejeva D; Kugler JM; Nguyen HT; Malmendal A; Holm ML; Toft BG; Loya AC; Cohen SM
BMC Cancer; 2018 Nov; 18(1):1180. PubMed ID: 30486822
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression.
Li Y; Pan Y; Zhao X; Wu S; Li F; Wang Y; Liu B; Zhang Y; Gao X; Wang Y; Zhou H
Clin Nutr; 2024 Feb; 43(2):332-345. PubMed ID: 38142478
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional landscape of DNA repair genes underpins a pan-cancer prognostic signature associated with cell cycle dysregulation and tumor hypoxia.
Chang WH; Lai AG
DNA Repair (Amst); 2019 Jun; 78():142-153. PubMed ID: 31054516
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
17. [Regulation of fat metabolism by PPARs].
Liu XF; Li H
Yi Chuan; 2006 Feb; 28(2):243-8. PubMed ID: 16520324
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-α signaling in hepatocarcinogenesis.
Misra P; Viswakarma N; Reddy JK
Subcell Biochem; 2013; 69():77-99. PubMed ID: 23821144
[TBL] [Abstract][Full Text] [Related]
19. PPARs: therapeutic targets for metabolic disease.
Berger JP; Akiyama TE; Meinke PT
Trends Pharmacol Sci; 2005 May; 26(5):244-51. PubMed ID: 15860371
[TBL] [Abstract][Full Text] [Related]
20. PPARs: fatty acid sensors controlling metabolism.
Poulsen Ll; Siersbæk M; Mandrup S
Semin Cell Dev Biol; 2012 Aug; 23(6):631-9. PubMed ID: 22273692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
